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Abstract
Maternal effect genes encode proteins that are produced during oogenesis and play an essential role during early
embryogenesis. Genetic ablation of such genes in oocytes can result in female subfertility or infertility. Here we report a
newly identified maternal effect gene, Nlrp2, which plays a role in early embryogenesis in the mouse. Nlrp2 mRNAs and their
proteins (,118 KDa) are expressed in oocytes and granulosa cells during folliculogenesis. The transcripts show a striking
decline in early preimplantation embryos before zygotic genome activation, but the proteins remain present through to the
blastocyst stage. Immunogold electron microscopy revealed that the NLRP2 protein is located in the cytoplasm, nucleus and
close to nuclear pores in the oocytes, as well as in the surrounding granulosa cells. Using RNA interference, we knocked
down Nlrp2 transcription specifically in mouse germinal vesicle oocytes. The knockdown oocytes could progress through
the metaphase of meiosis I and emit the first polar body. However, the development of parthenogenetic embryos derived
from Nlrp2 knockdown oocytes mainly blocked at the 2-cell stage. The maternal depletion of Nlrp2 in zygotes led to early
embryonic arrest. In addition, overexpression of Nlrp2 in zygotes appears to lead to normal development, but increases
blastomere apoptosis in blastocysts. These results provide the first evidence that Nlrp2 is a member of the mammalian
maternal effect genes and required for early embryonic development in the mouse.
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Introduction
Maternal factors, which are encoded by maternal effect genes
and accumulate during oogenesis, are critical to support the
development of the preimplantation embryo [1]. Maternal effect
genes were first described in mammals in 2000 [2,3], although
some early pioneering investigations had been reported in
Drosophila [4,5], Caenorhabditis elegans [6] and Xenopus [7]. Several
maternal effect genes that function in oogenesis [8], meiotic
maturation [9], preimplantation [8,10,11,12,13,14,15,16] and
postimplantation development [17] have been identified in the
mouse. However, knowledge of the maternal effect genes involved
in female reproduction and early embryo development is still
limited in mammals.
NLRP (Nucleotide-binding oligomerization domain, Leucine
rich Repeat and Pyrin domain containing Proteins) is a subfamily
of the newly described CATERPILLER (CAspase-recruitment
domain (CARD) Transcription Enhancer, R (purine)-binding,
Pyrin, Lots of LEucine Repeats) family of proteins with a
nucleotide-binding domain and a leucine-rich region [18,19].
The Nlrp gene family contains 20 members in the mouse. Recent
studies have demonstrated that these genes play key roles in
reproduction. For instance, the mouse Nlrp5 gene, known to
encode for the Maternal Antigen That Embryos Require
(MATER) [20], was one of the earliest maternal effect genes
characterized at the molecular level in the mouse. Although
showing fairly normal folliculogenesis, oocyte maturation and
fertilization, Nlrp5 knockout female mice are infertile because of a
block of embryogenesis at the 2-cell stage [3]. Recently a
subcortical maternal complex (SCMC), constituting MATER,
FLOPED, TLE6 and FILIA has been identified. This assembles
during oocyte growth, [15,21]. It is essential for zygotes to progress
beyond the first embryonic cell divisions. In vitro knockdown of
Nlrp14 in mouse zygotes leads to developmental arrest between the
2-cell and the 8-cell stages in more than 50% of the embryos [22].
Besides Nlrp5 and Nlrp14, several other Nlrp genes also display
specific or preferential oocyte expression patterns, the expression
of which declines with oocyte aging [22,23]. Additionally, in
studies on the oocyte-to-embryo transition in mouse, Nlrp2 (also
known as Nalp2/Pan1/Pypaf2) was shown to be highly enriched in
fully grown oocytes by reverse transcription polymerase chain
reaction (RT–PCR) amplification [24]. Based on these limited
previous studies, we hypothesized that Nlrp2 would be essential for
early embryo development and that perturbing its function in the
oocyte and zygote would disrupt early embryogenesis.
To test this hypothesis, we employed an RNA interference
(RNAi) approach to inhibit Nlrp2 function specifically in mouse
germinal vesicle (GV) oocytes and zygotes. This is an efficient
method for inhibiting the function of maternally and zygotically
expressed genes in oocytes and zygotes [25,26,27,28]. Electropo-
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most effective ways of delivering double stranded (ds)RNA and
small interfering (si)RNA into mouse oocytes and early embryos
[29,30]. In addition, we constructed an expression vector for Nlrp2
and microinjected it into mouse zygotes.
We report here that the maternal depletion of Nlrp2 in GV-
stage oocytes and zygotes results in early developmental arrest.
However, overexpression of Nlrp2 in zygotes appears to lead to
normal development, but increases apoptosis in blastocyst. In
addition, Nlrp2 is not required for oocyte maturation. Thus, Nlrp2
can be added to the increasing—if limited—list of mammalian
maternal effect genes.
Results
Nlrp2 mRNA Expression Levels
Nlrp2 expression was detected in mouse ovaries, but not in
eleven other tissues, including male testes (Fig. 1A). Within the
ovary, expression was restricted to ovarian follicles at various
stages (Fig. 1B). After ovulation and fertilization, the transcripts
Figure 1. Developmental expression of Nllrp2 in the mouse. (A) Quantitative reverse-transcription polymerase chain reaction (qRT–PCR) with
total RNA extracted from 4-week-old mouse ovary (Ov), uterus (Ut), testis (Te), kidney (Ki), lung (Lu), heart (He), liver (Li), brain (Br), stomach (St),
intestines (In), muscle (Mu), spleen (Sp) were performed. Results were normalized to the abundance in the ovary and expressed as the mean 6 SEM.
(B) In situ hybridization of fixed, paraffin wax-embedded 6 mm ovary sections probed with DIG-labeled Nlrp2 oligonucleotide probes. The original
magnification was6100. (C) The relative abundance of Nlrp2 transcripts in mouse oocytes and preimplantation embryos. (D) The relative abundance
of Nlrp2 transcripts in different mouse cells.
doi:10.1371/journal.pone.0030344.g001
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stage during preimplantation development (Fig. 1C). In addition,
except for oocytes and cumulus cells, Nlrp2 mRNA was not
detected in other cell lines (Fig. 1D), although human NLRP2 is
expressed in various tumor lines [31].
NLRP2 Protein Levels
Immunohistochemistry, immunofluorescence and immunoblot-
ting were used to assess expression at the protein level.
Immunohistochemistry of ovarian sections suggested that the
NLRP2 protein was expressed in oocytes and granulosa cells at
various follicular stages (Fig. 2A). After ovulation and fertilization,
the protein (,118 KDa) was still present in cumulus–oocyte
complexes (Fig. 2B) and remained present through the blastocyst
stage (Fig. 2C) although Nlrp2 mRNA was not detected after the 2-
cell stage (Fig. 1C).
Cellular and Subcellular Localization of NLRP2
To determine the location of NLRP2 protein in oocytes and
early embryos, we conducted confocal and immunogold electron
microscopy analyses. Confocal microscopy demonstrated a
predominant cytoplasmic location of the NLRP2 protein in
oocytes and early embryos (Fig. 3). The distribution of NLRP2
protein in the subcellular organelles was monitored by immuno-
gold staining and transmission electron microscopy. Immunogold
particles were seen within the oocytes and the surrounding
granulosa cells. They were mainly located in the cytoplasm, but
some particles were present in the nucleus and close to nuclear
pores in the oocytes (Fig. 4A), as well as the surrounding granulosa
cells (Fig. 4B).
Expression and Localization of Nlrp2 in Parthenogenetic
Embryos
The amount of Nlrp2 mRNA declined sharply after partheno-
genetic activation of metaphase II oocytes (Fig. 5A). As the
parthenogenetic embryos developed beyond the 2-cell stage, the
transcripts virtually disappeared (Fig. 5A). However, the NLRP2
protein remained present at preimplantation stages (Fig. 5B). The
protein was predominately localized in the blastomere cytoplasm
(Fig. 5C). Thus, the expression profile of NLRP2 protein during
embryogenesis, as determined by immunoblotting assay, was
similar to that determined by confocal microscopic analysis.
Nlrp2 Is Not Required for Oocyte Maturation
Zona-weakened germinal vesicle (GV)-stage oocytes were
electroporated with custom-made Nlrp2 siRNA mixture. As
shown in Figure 6A, Nlrp2 siRNA had no obvious effect on
oocyte maturation. However, the Nlrp2 gene was downregulated in
a dose-dependent manner (Fig. 6B). The Nlrp2 knockdown effects
were specific as the expressions of Nlrp4f, Nlrp5, Nlrp9c and Nlrp14,
randomly selected members of the Nlrp gene family associated with
reproduction and embryo development, were not altered by the
Figure 2. Developmental expression of NLRP2 protein in mouse. (A) Immunohistochemical analysis of sequential sections from a 3-week-old
mouse ovary using an anti-NLRP2 antibody. The original magnification was 640. (B) Immunofluorescent detection of NLRP2 in cumulus–oocyte
complexes after permeabilization and incubation with an anti-NLRP2 antibody. The original magnification was 6100. (C) Immunoblots of lysates
isolated from oocytes and preimplantation embryos. Molecular masses (KDa) are indicated on the left; b-actin was used as a control.
doi:10.1371/journal.pone.0030344.g002
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of NLRP2 protein levels by immunoblotting showed that this
obviously decreased in oocytes 24 h after electroporation with
Nlrp2 siRNA compared with control groups (Fig. 6D). Thus, the
decline of Nlrp2 mRNA and protein in oocytes after electropora-
tion with Nlrp2 siRNA did not affect oocyte maturation.
Nlrp2 Knockdown in Oocytes Leads to Early Embryonic
Arrest After Parthenogenetic Activation
Metaphase II oocytes (after extrusion of the first polar body)
derived from oocytes electroporated at the GV stage were
subjected to parthenogenetic activation and then cultured in
KSOMaa-BSA medium (see Materials and Methods). There was
no significant difference in the parthenogenetic activation rate of
the oocytes obtained from the EP control, control siRNA or Nlrp2
siRNA (20, 40 and 60 nM) groups (Fig. 7A). The embryonic
developmental stages and their morphological appearance after
being cultured for 3.5 days are presented in Figure 7B. The
parthenogenetic embryos derived from the electroporation (EP)
control and control siRNA reached the blastocyst stage at rates of
65% and 63%, respectively (Fig. 7C). However, the development
of parthenogenetic embryos derived from Nlrp2 siRNA-electropo-
rated oocytes appeared to be blocked mainly at the 2-cell stage
(Fig. 7C).
Nlrp2 Knockdown in Zygotes Causes Early Embryonic
Arrest
To further confirm the function of Nlrp2 in early embryonic
development, the zygotes were electroporated with Nlrp2 siRNA.
As shown in Figure 8A, the introduction of Nlrp2 siRNA resulted
in the reduction of the targeted mRNA in time- and concentra-
tion-dependent manners. Moreover, it also led to a decrease in the
NLRP2 protein level compared with control groups (Fig. 8B).
Morphological analysis suggested that embryos derived from Nlrp2
siRNA-electroporated zygotes appeared to be arrested, while the
embryos derived from control groups reached the blastocyst stage
(Fig. 9). The Nlrp2 knockdown embryos were mainly arrested
between the 2- and 8-cell stages (Fig. 10).
Overexpression of Nlrp2 in Zygotes Leads to Normal
Development but Increased Apoptosis
As described above, the knockdown of Nlrp2 with target-specific
siRNA in oocytes or zygotes led to early developmental arrest.
However, the effect of overexpression in zygotes is unknown. To
determine this, zygotes were microinjected with pIRES2-AcGFP1-
Nuc-Nlrp2 (pIRES2-Nlrp2), a bicistronic vector independently
expressing NLRP2 and green fluorescent protein (GFP) (see
Materials and Methods). Zygotes microinjected with pIRES2-
Nlrp2 or pIRES2-AcGFP1-Nuc (pIRES2) reached the blastocyst
stage and expressed GFP (Fig. 11A). The rates of blastocyst
formation were similar between the two groups (Fig. 11B). As
shown in Figure 11C, the Nlrp2 transcripts were reduced
dramatically and were undetectable after the 2-cell stage in the
control group. However, the expression of Nlrp2 persisted during
preimplantation development in the group microinjected with
pIRES2-Nlrp2. As expected, the level of NLRP2 protein in the
pIRES2-Nlrp2-microinjected group gradually increased during
preimplantation stages compared with the control group
(Fig. 11D). To confirm whether accumulation of NLRP2 protein
would influence cell fate and differentiation in blastocysts, we
investigated the expression levels of OCT3/4 and CDX2, markers
of pluripotency and trophectoderm differentiation [32,33,34,35],
respectively. The final cell fate and differentiation was not affected
with regard to the expression of these markers (Fig. 12A). We also
examined whether accumulation of NLRP2 protein would lead to
apoptosis in blastocysts. We found that the number of apoptotic
blastomeres in the pIRES2-Nlrp2 microinjected group was
significantly increased compared with the control group
(Fig. 12B, C).
Figure 3. Cellular localization of NLRP2 protein. Confocal
microscopic images of oocytes and preimplantation embryos. Each
sample was counterstained with DAPI to visualize DNA (blue). The
original magnification was 6200.
doi:10.1371/journal.pone.0030344.g003
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The Nlrp gene family plays a pivotal role in the innate immune
[36,37,38,39,40,41,42,43,44] and reproductive systems [3,22,45,
46,47,48] in mammals. Nlrp5 (Mater) and Nlrp14 are members of
this family and are required for early embryonic development
[3,22]. We report here that Nlrp2, another member of this family,
is a newly identified maternal effect gene. It is essential for female
fertility, because developmental competence is dramatically
compromised in Nlrp2 knockdown oocytes and zygotes. Our data
demonstrate that maternal depletion of Nlrp2 blocks early
embryogenesis in the mouse.
Maternal effect genes encode proteins that are produced during
oogenesis and play a role during early embryogenesis. We
demonstrated here that the temporal and spatial patterns of Nlrp2
expression were developmentally regulated in a manner typical of
maternal effect genes. Nlrp2 mRNA appeared to accumulate
during oogenesis and degrade after zygotic genome activation.
Hence, the source of embryonic Nlrp2 transcripts is maternal and
does not come from expression of the zygotic genome during
preimplantation development. NLRP2 proteins were detected at
different stages of follicle development, suggesting that the Nlrp2
gene is involved in transcription–translation coupling and might
play a role during folliculogenesis. After the 2-cell stage in
Figure 4. Subcellular localization of NLRP2 protein. (A) Subcellular localization of NLRP2 protein in immature mouse oocytes. Using an anti-
NLRP2 antibody and ultrathin ovarian sections of 10-day-old mice, immunogold reactions were examined by transmission electron microscopy. Black
spots with arrows are immunogold particles indicating the presence of NLRP2 protein. a, Oocytes and surrounding granulosa cells (64,000). The
positions of nucleus (i), cytoplasm (ii) and granulosa cells (iii) are indicated. b and c, Oocyte cytoplasm with immunogold particles (650,000). d,
Nucleus with immunogold particles (650,000). e, Nuclear pore with immunogold particles nearby (650,000). f, Control oocyte without immunogold
particles in the absence of the primary antibody (650,000). (B) Subcellular localization of NLRP2 protein in mouse granulosa cells. a, Granulosa cell
(615,000). The positions of the nucleus (i) and cytoplasm (ii). b and c, Cytoplasm with immunogold particles (650,000). d, Nucleus with immunogold
particles (650,000). e, Nucleus and nuclear pore with immunogold particles (650,000). f, Granulosa cell without immunogold particles in the absence
of primary antibody (650,000).
doi:10.1371/journal.pone.0030344.g004
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through to the blastocyst stage. The expression patterns of Nlrp2
mRNA and its protein in parthenogenetic embryos were identical
to those in normally fertilized embryos, suggesting that Nlrp2 might
be involved in two different developmental processes, but fulfill the
same function.
The NLRP2 protein was distributed predominantly in the
cytoplasm both in normal fertilized embryos and parthenogenetic
embryos as shown by confocal microscopy. Immunogold electron
microscopy demonstrated that the protein was present in the
cytoplasm and close to nuclear pore complexes. In addition,
immunogold particles were detected within the nucleus. However,
the NLRP2 sequence does not display a nuclear localization signal.
It is likely that other proteins interacting with NLRP2 mediate its
transport into the nucleus; indeed, this protein contains leucine-
rich repeat domains, which are known to participate in protein–
protein interactions [49,50,51]. The subcellular localization of
NLRP2 protein differs from NLRP5 (MATER) in mouse [52] and
bovine oocytes [53]. Such localization of NLRP2 in multiple
organelles suggests its participation in different intracellular
functions.
Mouse embryos with mutations in maternal effect genes are
characterized by developmental arrest during oogenesis or
embryogenesis. Among the known maternal effect genes, only
Formin-2
2/2 and basonuclin-deficient oocytes cannot undergo
normal maturation [8,9]. Compared with Formin-2 null and
basonuclin-deficient oocytes, Nlrp2 knockdown GV-stage oocytes
could reach metaphase II and emit the first polar body, suggesting
that Nlrp2 is not required for the metaphase spindle positioning or
migration. Moreover, Nlrp2 deficiency in oocytes does not perturb
RNA polymerase I- or -II-mediated transcription, as the
disruption of these processes leads to abnormal oocyte maturation
[8,9,54]. However, the parthenogenetic embryos derived from
Nlrp2 knockdown oocytes were mainly arrested at the 2-cell stage.
Interestingly, the expression levels of Nlrp4f, Nlrp5, Nlrp9c and
Nlrp14 were not affected in Nlrp2 knockdown oocytes, suggesting
that the expression of other Nlrp genes was not able to compensate
for the absence of Nlrp2. Furthermore, the predominant 2- and 8-
Figure 5. Developmental expression and localization of Nlrp2 in parthenogenetic embryos. (A) The relative abundance of Nlrp2
transcripts in mouse oocytes and parthenogenetic embryos. (B) Immunoblots of lysates isolated from parthenogenetic embryos. (C) Confocal
microscopic images of parthenogenetic embryos. Each sample was counterstained with DAPI to visualize DNA (blue). The original magnification was
6200.
doi:10.1371/journal.pone.0030344.g005
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suggests that this maternal factor functions in early embryonic
development. Previous studies also indicated that targeted
invalidation/depletion of Nlrp5 and Nlrp14 does not reveal any
gene compensation. In addition, microinjection with the pIRES2-
Nlrp2 vector into zygotes did not affect subsequent cell fate and
differentiation in terms of the expression and localization of
OCT3/4 or CDX2. However, overexpression of Nlrp2 increased
the incidence of apoptosis in blastocysts, implying that an excessive
accumulation of NLRP2 protein might impair the viability of
blastomeres or activate the pathway of cell apoptosis, because
NLRP2 contains a pyridine domain at the amino terminal that is
primarily involved in apoptosis [55,56,57].
There are several reproduction-related Nlrp genes with
conserved functions in mammals and primates. Nlrp5 (NLRP5)
transcripts are detected in the ovary in the mouse [3,20], bovine
[53,58,59], pig [60], rhesus macaque monkeys [28,48] and
humans [61]. Moreover it has been demonstrated that Nlrp5 plays
key roles in early embryo development in the mouse [3] and rhesus
macaque monkeys [28]. Nlrp14 is continuously expressing in germ
cells [62] and in vitro knockdown experiments in zygotes led to
developmental arrest in the mouse [22]. Moreover mutations in
the testis-specific NLRP14 gene in men leads to spermatogenic
failure [63], implying that these genes are conserved functionally
in a wide range of mammalian reproductive systems. Germline
mutations in NLRP2 result in a familial imprinting disorder
(Beckwith–Wiedemann Syndrome) in humans [64], suggesting
that this gene might have a similar function in the establishment
and/or maintenance of genomic imprinting/methylation in the
mouse. The Dnmt1o mutation causes disrupted genomic imprinting
in early mouse embryogenesis [17]. Moreover, a gene disruption
study determined that PGC7/Stella is indispensable for the
maintenance of methylation involved in epigenetic reprogram-
ming after fertilization [11,65,66]. Thus, the function of Nlrp2
might be similar to the maternal effect gene Dnmt1o and/or PGC7/
Stella during early preimplantation development. However, the
Figure 6. GV-stage oocyte maturation after electroporation with Nlrp2 siRNA. (A) Oocyte maturation rate following electroporation (EP) of
GV-stage oocytes in the presence or absence of control and Nlrp2 siRNA. The numbers on top of each bar indicate the numbers of oocyte matured/
numbers of oocytes electroporated. (B) The relative abundance of Nlrp2 transcripts after electroporation with Nlrp2 siRNA. The data have been
normalized to untreated oocytes. Statistical comparisons were made using ANOVA and LSD tests (* p,0.05). (C) Nlrp2, Nlrp4f, Nlrp5, Nlrp9c and Nlrp14
gene expression by qRT–PCR in mouse oocytes at 24 h after electroporation with Nlrp2 siRNA (60 nM). Results were normalized to control siRNA
(100 nM) group. * p,0.05. (D) Immunoblots of mouse oocytes at 24 h after electroporation in the presence or absence of control and Nlrp2 siRNA.
doi:10.1371/journal.pone.0030344.g006
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different, so the molecular function of Nlrp2 may be different from
Dnmt1o and PGC7/Stella. Identification of proteins that interact
with NLRP2 could provide insights into the roles of this maternal
factor in regulating the critical stages of development from the
oocyte to the preimplantation embryo.
In summary, our data demonstrate that Nlrp2 is a maternal effect
gene and required for early embryonic development in the mouse.
The maternal depletion of Nlrp2 in zygotes by RNAi results in early
embryonic arrest. Nlrp2 knockdown oocytes can progress through
the metaphase of meiosis I and emit the first polar body; however,
the development of parthenogenetic embryos derived from Nlrp2
knockdown oocytes mainly arrest at the 2-cell stage. In addition,
overexpression of Nlrp2 in zygotes appears to permit normal
development, but increases the incidence of apoptosis in blastocysts.
Materials and Methods
Ethics Statement
The experimental procedure was approved by the Animal Care
Commission of the College of Veterinary Medicine, Northwest
A&F University. Adult male and female ICR strain mice were
Figure 7. Development of parthenogenetic embryos derived from EP control, control siRNA and Nlrp2 siRNA-treated groups (20, 40
and 60 nM). (A) Parthenogenetic activation rate of electroporated oocytes. (B) Morphological appearance of parthenogenetic embryos after being
cultured for 3.5 days. The original magnification was6100. (C) Percentage of parthenogenetic embryos at different stages after being cultured for 3.5
days.
doi:10.1371/journal.pone.0030344.g007
Nlrp2 is Required for Early Embryonic Development
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e30344purchased from the Experimental Animal Center of The Fourth
Military Medical University (Xi’an, China). They were maintained
on a 14/10 h light/dark cycle with free access to food and water in
the Laboratory Animal Facility of the College of Veterinary
Medicine, Northwest A&F University.
Chemicals
All chemicals and reagents were purchased from Sigma-Aldrich
(St. Louis, USA) unless stated otherwise. Sterile plastic ware was
purchased from Nunclon (Roskilde, Denmark).
Collection and Culture of Oocytes and Embryos
Oocytes at the GV stage were obtained from the ovaries of 8–
10-week-old females injected with 10 IU of pregnant mare serum
gonadotrophin (PMSG) to stimulate the growth of the follicles.
Forty-eight hours after PMSG administration the ovaries were
placed in Hepes-buffered KSOM medium (H-KSOM) [67]
containing 0.1 mM 3-isobutyl-1-methyl-xanthine to inhibit re-
sumption of meiosis and oocytes were released from the largest
follicles by puncturing them with hypodermic needle. The oocytes
were completely freed of attached cumulus cells by repeated
mouth pipetting.
Mature oocytes arrested in metaphase II were recovered from
mice superovulated with intraperitoneal injections of PMSG and
human chorionic gonadotrophin (hCG) 48 h apart. Metaphase II
oocytes were collected from the oviduct ampullae at 16 h after the
hCG injection. Cumulus masses were treated with hyaluronidase
(1 mg/ml) to release ova. Metaphase II oocytes and cumulus cells
were collected separately.
Zygotes (1-cell embryos) were obtained from females induced to
superovulate as described above and mated with males immedi-
ately after hCG injection. Zygotes were collected from the oviducts
14 h after hCG injection. Cumulus cells surrounding zygotes were
removed by brief exposure to hyaluronidase. Collection of
Figure 8. Nlrp2 mRNA and protein levels in Nlrp2 knockdown
embryos. (A) The relative abundance of Nlrp2 transcripts in mouse
embryos collected at 2 h, 11 h, 20 h, 29 h and 38 h after electropora-
tion. Results have been normalized to the abundance in untreated
zygotes and are expressed as the mean 6 SEM. (B) Immunoblots of
mouse embryos at 4 h (1-cell), 28 h (2-cell) and 52 h (8-cell) after
electroporation.
doi:10.1371/journal.pone.0030344.g008
Figure 9. Morphology of Nlrp2 knockdown embryos after being
cultured for 3.5 days. Morphology (left) and DAPI staining (right).
The original magnification was 6100.
doi:10.1371/journal.pone.0030344.g009
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performed according to previously described protocols [30].
Embryos were cultured in groups of 30–50 in microdrops
(100 ml) of KSOMaa medium [68] supplemented with 4 mg/ml
bovine serum albumin (KSOMaa-BSA) under liquid paraffin oil in
a humidified atmosphere of 5% CO2/95% air at 37uC.
Parthenogenetic Activation of Oocytes
Metaphase II oocytes were subjected to parthenogenetic
activation by exposure to activation medium (Calcium-free
KSOMaa, 10 mM strontium chloride and 5 mg/ml cytochalasin
B) for 6 h. The oocytes were washed in H-KSOM and cultured in
KSOMaa-BSA. Pronuclear formation was scored and only
activated embryos were used for quantitative RT–PCR, immu-
noblotting and immunofluorescence.
Collection of Spermatozoa
Epididymides were removed from mature 12-week-old ICR
male mice and punctured with hypodermic needles. The tissues
were compressed to release spermatozoa into 1.5 ml polypropyl-
ene centrifuge tubes; 500 ml of H-KSOM medium was added to
each tube. Then the tube was centrifuged (3000 rpm, 3 min) to
collect spermatozoa.
Cell Culture
RAW264.7 murine macrophage-like cells were maintained in
RPMI 1640 medium (Gibco, Grand Island, NY, USA) supple-
mented with 10% fetal bovine serum (FBS, Gibco). Mouse D3
embryonic stem (D3 ES) cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco) supplemented with
20% FBS, 2 mM glutamine, 1% nonessential amino acids
(Invitrogen, Carlsbad, CA, USA) and 0.1 mM b-mercaptoethanol.
1000 U/ml murine leukemia inhibiting factor (mLIF) was added
to the culture medium to maintain ES cell pluripotency. Mouse F9
teratocarcinoma stem cells (F9 ES) were grown in DMEM
supplemented with 10% FBS. Mouse D3 ES and F9 ES were
plated on gelatinized multiwell tissue culture plates each
containing 2 ml of medium. EMT6 mouse mammary carcinoma
cells were cultured in Waymouth’s medium (Invitrogen) supple-
mented with 15% FBS. All cell media were supplemented with
50 U/ml penicillin (Invitrogen) and 50 mg/ml streptomycin
(Invitrogen). Cells were cultured at 37uC in a humidified 5%
CO2/95% air incubator.
RNA Isolation and Quantitative Real-Time RT–PCR
Total RNA extracts from 4-week-old mouse tissues (ovary,
uterus, testis, kidney, lung, heart, liver, brain, stomach, small
intestine, muscle and spleen) and different cells (RAW264.7, D3
ES, F9 ES, EMT6, cumulus cells and spermatozoa) were purified
with RNeasy Mini Kits (Qiagen, Valencia, CA, USA). cDNA
synthesis was performed using PrimeScript II 1st Strand cDNA
Synthesis Kit (TaKaRa, Otsu, Japan).
Pooled oocytes or embryos (10 per group) were lysed and first-
strand cDNA directly was synthesized using SuperScriptH III
CellsDirect cDNA Synthesis Kit (Invitrogen) according to the
manufacturer’s protocol. Lysis and reverse transcription were
performed in the same tube. DNase I was added to eliminate
genomic DNA prior to first strand synthesis. After synthesis, the
first-strand cDNAs were amplified with specific primers by
quantitative (q)RT–PCR. The primer pairs used for qRT–PCR
are shown in Table 1. Each primer pair was confirmed by
performing electrophoresis and melting temperature analysis of
the PCR product to ensure its correct size and the absence of
primer dimers. For negative controls, deionized water replaced
cDNA in the real-time reaction tubes. The mRNA levels were
quantified using SYBR Premix ExTaq
TM II (TaKaRa) on an ABI
PRISM 7700 Sequence Detection System (Applied Biosystems,
Inc., Carlsbad, CA, USA). Samples were denatured at 95uC,
1 min and then subjected to 40 cycles of amplification (95uC, 5 s;
60uC, 30 s). Each data point was the average of duplicate assays
performed on three independently obtained samples and tran-
script levels were calculated relative to the transcription of the
housekeeping gene b-actin in every sample. Fold changes for each
gene were calculated using the 2
2DDCT method [69].
In Situ Hybridization
Ovaries from 3-week-old mice were fixed in 4% paraformalde-
hyde in 0.1 M PBS for 1 h before dehydration and paraffin wax
embedding and sectioning (6 mm). Hybridization was carried out
with Nlrp2 ISH Detection Kits (Boster-Bio, MK-3516-m, Wuhan,
China) according to the manufacturer’s instructions. The dig-
oxigenin (DIG)-labeled oligonucleotide sequences used for in situ
hybridization were 59–GTGACTCTCTTTATCCAAGCACTG-
GGGCAGTGGTC–39 59–GGCCAGAAGTTCTGCTTCCAT-
TTAGCTGTGTATCT–39 59–GGAGGGCCATGCAGCACA-
ATTGCATGAGCAAATGG–39 for Nlrp2. After deparaffiniza-
tion and rehydration, sections were permeabilized with proteinase
K (Boster-Bio) for 30 s and washed three times in 0.1 M PBS.
Then the sections were postfixed in 1% paraformaldehyde for
10 min, prehybridized for 4 h at 42uC and hybridized overnight at
42uC. After hybridization, the sections were rinsed in 26 SSC
buffer for 10 min at 37uC, 0.56SSC for 15 min and twice in 0.26
SSC for 20 min at 37uC. Hybridized probes on sections were
detected immunologically: sections were labeled with biotinylated
anti-DIG antibody (Boster-Bio) and detected with Avidin,
biotinylated peroxidase and DAB substrate solution (Boster-Bio)
for 20–30 min at room temperature (RT). Control sections had
the Nlrp2 probes omitted. Hybridization signals were examined
using a Nikon Eclipse Ti-S microscope equipped with a 198 Nikon
DS-Ri1 digital camera (Nikon, Tokyo, Japan).
Figure 10. Developmental stages of Nlrp2 knockdown embryos.
Percentage of embryos at different stages after being cultured for 3.5
days.
doi:10.1371/journal.pone.0030344.g010
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Ovaries were collected from 3-week-old mice and fixed in 4%
paraformaldehyde overnight, dehydrated through graded alcohol
solutions and embedded in paraffin wax. Six-micrometer sections
were deparaffinized in xylene, rehydrated through graded alcohol
solutions and heated in 10 mM sodium citrate buffer (pH 6.0) with
microwaves (15 min at medium power) and cooled to room
temperature for antigen retrieval. Sections were then incubated
with 10% nonimmune goat serum (Maixin-Bio, Kit-7770, Fuzhou,
China) to block nonspecific sites followed by incubation with the
NLRP2 polyclonal antibody (Sigma-Aldrich, SAB3500325) in
blocking solution (1:200 dilution of rabbit anti-NLRP2 antibody;
Beyotime, P0102, Jiangsu, China) overnight at 4uC. For enzymatic
staining, sections were incubated for 10 min at RT with a
biotinylated goat anti-rabbit secondary antibody (Maixin-Bio).
Following three 5 min washes in PBS buffer with 0.1% Triton X-
100 (PBST), sections were incubated at RT for 10 min with
streptavidin-linked alkaline phosphatase (Maixin-Bio) and then
washed three times for 5 min each in PBST. 5-bromo-4-chloro-3-
indolyl phosphate/nitro blue tetrazolium (BICP/NBT) substrate
solution (Maixin-Bio) was applied to the sections for 10–30 min
and the reaction was stopped by rinsing in PBS. Sections were
then mounted with AEC Mounting Solution (Maixin-Bio, AEC-
0038). Negative controls consisted of identical reactions with the
omission of the primary antibody.
Immunoblotting
To determine protein levels, fifty oocytes or embryos were
loaded per lane. Total protein contents were separated by SDS-
polyacrylamide gel (8%) and transferred to a PVDF membrane
(Millipore, Bedford, MA) using semi-dry transfer. The membrane
was blocked for 4 h at RT in Tris-buffered saline (TBS pH 7.4)/
Figure 11. Overexpression of Nlrp2 in zygotes. (A) Representative micrographs of blastocysts developing from zygotes that had been
microinjected with pIRES2 or pIRES2-Nlrp2. Fluorescence images show the expression of GFP. The original magnification was6100. (B) The blastocyst
formation rate of zygotes microinjected with pIRES2 or pIRES2-Nlrp2. (C) The relative abundance of Nlrp2 transcripts after microinjection. (D)
Immunoblots of mouse embryos at different stages after microinjection.
doi:10.1371/journal.pone.0030344.g011
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incubation overnight at 4uC with an anti-NLRP2 antibody
(Sigma-Aldrich) at a 1:1000 dilution, After several washes in
TBS/Tween 20, membranes were incubated for 2 h at RT with a
horseradish peroxidase-linked secondary antibody goat anti-rabbit
(Pierce, Rockford, IL, USA) at a 1:2000 dilution. The membrane
was washed five times in TBS/Tween 20. Finally, the enhanced
chemiluminescence (ECL) Advance Western Blotting detection
system (Pierce) was used according to the manufacturer’s
instructions. Detection of actin, with anti-b actin polyclonal rabbit
antibody (1:1000, Santa Cruz Biotechnology Inc., sc-130656,
Santa Cruz, CA, USA) and secondary anti-rabbit antibody
(1:5000, Pierce) was used as a loading control.
Immunofluorescence
Oocytes and embryos were fixed in 4% paraformaldehyde in
PBS for 45 min and permeabilized in PBS, 0.2% Triton X-100 for
10 min at RT. After a treatment with 3% BSA in PBS for 1 h,
samples were incubated with the primary antibody diluted in PBS
containing 1% BSA overnight at 4uC. Rabbit anti-NLRP2
antibodies (Sigma) were diluted 1:100, anti-CDX2 rabbit poly-
clonal IgG (Santa Cruz, sc-134468) and anti-OCT3/4 mouse
monoclonal antibody (Santa Cruz, sc-5279) was diluted 1:50,
respectively. After washing in PBS containing 0.3% polyvinylpyr-
rolidone (PBS/0.3% PVP), samples were incubated 1 h at RT
with the secondary antibodies of Cy3-labeled goat anti-rabbit-IgG
(Beyotime, A0516) for NLRP2, Alexa Fluor 555-labeled goat anti-
Figure 12. Effects of Nlrp2 overexpression on the expression of CDX2 and OCT3/4 and incidence of apoptosis in blastocysts. (A)
Immunostaining of CDX2 (red) and OCT3/4 (green) in morulae and blastocysts developing from zygotes that had been microinjected with pIRES2 or
pIRES2-Nlrp2. The original magnification was 6200. (B) TUNEL apoptosis assay of blastocysts (green). Each sample was counterstained with DAPI to
visualize DNA (blue). The original magnification was 6200. (C) Number of apoptotic cells in each blastocyst. *p,0.05.
doi:10.1371/journal.pone.0030344.g012
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labeled goat anti-mouse IgG (Beyotime, A0428) for OCT3/4. The
secondary antibodies were diluted 1:500 with PBS containing 1%
BSA. After washing in PBS/0.3% PVP, nuclei were stained with
DAPI (Beyotime, C1005) for 5 min. Negative controls were
determined by processing samples as described above in the
absence of primary antibody. Samples were observed using a
Nikon eclipse Ti-S microscope (Nikon) or a Zeiss LSM510
confocal microscope equipped with differential interference
contrast optics (Carl Zeiss, Inc., Thornwood, NY).
Immunogold electron microscopic analysis
Ovaries from 10-day-old mice were fixed in 2.5% glutaralde-
hyde in 0.1 M phosphate buffer (PB) overnight at 4uC and washed
thrice in fresh 0.1 M PB and then transferred into 1% osmium
tetroxide in 0.1 M PB for 2 h at 4uC. After dehydrating in graded
acetone, the ovaries were embedded in epoxy resin (Durcupan
ACM, FLUKA, Buchs, Switzerland) and sectioned (70 nm) with a
diamond knife mounted in an Ultracut microtome (Leica,
Mannheim, Germany). The sections were mounted on nickel
grids for immunogold reactions as described [52]. Briefly, the
sections were subjected to blocking buffer and then incubated
overnight at 4uC in droplets of rabbit anti-NLRP2 antibody
(1:500, Sigma-Aldrich). At the end of incubation, the sections were
washed thrice to remove excess primary antibody and incubated
again in blocking buffer and then incubated with droplets of the
gold-labeled (10 nm) goat anti-rabbit IgG (1:50; Sigma-Aldrich,
G7402) for 2 h at RT. After several washings in 0.1 M PB and
deionized water, the sections were counterstained with 2% uranyl
acetate and lead citrate. Negative controls consisted of samples not
incubated with the primary antibody. The sections were observed
with a JEM-1230 electron microscope (JEOL Ltd., Tokyo, Japan).
GV-stage oocyte and zygote electroporation with custom
siRNA
Electroporation was used to introduce siRNA into mouse
oocytes and zygotes as described [30]. GV-stage oocytes or zygotes
were collected and washed in H-KSOM, then incubated in
prewarmed acid Tyrode’s solution for 12 s to weaken the zona
pellucida [29]. They were then washed twice in fresh H-KSOM
and kept in the pre-made KSOMaa drops. Afterwards, the
siPORT Amine Transfection Agent (Ambion, AM4502, Austin,
TX, USA) was diluted in Opti-MEMH I (Invitrogen) medium and
incubated for 10 min at RT. The negative control siRNA
(Ambion, SilencerH negative control #1, AM4611) or the
custom-made Nlrp2 siRNA (mixture of three target-specific 19–
25 nt siRNA designed to knock down mouse Nlrp2 expression;
Santa Cruz, sc-149811) was diluted into Opti-MEMH I (Invitro-
gen) medium. The diluted negative control siRNA or the diluted
custom-made Nlrp2 siRNA were combined with the diluted
siPORT Amine Transfection Agent and incubated for 10 min at
RT. The GV-stage oocytes or zygotes were mixed with the
transfection complexes. Simultaneously, the cell fusion instrument
(BTX Inc., ECM 2001; San Diego, CA) was switched on. The
GV-stage oocytes or zygotes were linearly arranged in a flat
electrode chamber (BTX Inc.) and electroporated with the
negative control siRNA (100 nM) and the Nlrp2 siRNA in different
concentrations (20, 40 and 60 nM). The electroporation condition
was DC 20 volts/1 ms pulse length/3 pulses/0 repeats. The blank
siPORT
TM electroporation buffer was used as electroporation
control (EP control). The negative control siRNA was used as
siRNA control (Control siRNA).
Following electroporation, the GV-stage oocytes were washed
thrice and cultured in MEM media supplemented with 3 mg/ml
BSA. The maturation rates of oocytes were calculated after 24 h in
vitro culture. Some mature oocytes were processed for qRT–PCR
and immunoblotting, others were subjected to parthenogenetic
activation and the subsequent development was analyzed. After
electroporation, zygotes were washed thrice and cultured in
KSOMaa-BSA. Some embryos were collected at 2 h (early 1-cell),
11 h (later 1-cell), 20 h (early 2-cell), 29 h (mid 2-cell) and 38 h
(later 2-cell) post-electroporation for qRT–PCR. Some were
collected at 4 h (1-cell), 28 h (2-cell) and 52 h (8-cell) post-
electroporation for immunoblotting.
Construction of NLRP2 expression vector and
microinjection
Nlrp2 full-length CDS (3141 bp from 75 to 3215) with Sal I and
Xma I sites in the 59 and 39 ends was obtained through PCR
amplified (sense primer 59–GCAGTCGACCATGGAACATT-
TTGATCCCCT–39 antisense primer 59–ATCCCGGGTTA-
AAAAATGAAATGAGGAAG–39). The PCR product was di-
gested with Sal I and Xma I and inserted to the Sal I/Xma I-
digested pIRES2-AcGFP1-Nuc (Clontech) eukaryotic expression
vector. The recombinant expression plasmid was then sequenced.
Zygotes were placed into a micro-culture dish at RT and
microinjected with pIRES2-AcGFP1-Nuc-Nlrp2 (pIRES2-Nlrp2).
Microinjection was performed using a Narishige microinjector
connected to a micromanipulation system (Nikon, Tokyo, Japan).
Approximately 5 pl of 0.8 mg/ml solution of expression plasmid
was injected into the cytoplasm of per zygote. Zygotes were kept in
H-KSOM during injection and then cultured in KSOMaa-BSA.
Zygotes injected with pIRES2-AcGFP1-Nuc (pIRES2) were used
as control. Embryos were collected for qRT–PCR and immuno-
blotting assays at different stages.
TUNEL labeling assay
TUNEL (TdT-mediated dUTP nick end labeling) apoptosis
assays were carried out with the DeadEnd
TM Fluorometric
TUNEL System (Promega, Madison, WI) according to the
manufacturer’s instructions. Apoptosis assays of blastocysts were
performed as described [70].
Table 1. Primer sequences for quantitative real-time PCR.
Genes Primer sequences (59-39) Tann
a (6C)
Nlrp2 F
b: AACACTGAGCCTGAAACACTTGGA 60
R
c: CAGTTCAGTGGAGTGATGGAGCA
Nlrp4f F: CTTGAACCAGGCAGAGTGCAAC 60
R: TGCCAAATTAAGAACCTTCAACGAC
Nlrp5 F: CCAGAGCAGGAGCAGACATC 60
R: TTCCAATCCACGTGCTTTCA
Nlrp9c F: CGCAATTGTACACACATTATCCAAG 60
R: TCAGGCATATAAGTGTTGGTCTCAG
Nlrp14 F: TTCTCAGCGCAAGGACTTAACTTTC 60
R: AGTCTTTGTCCTCACTCACGGTTTC
b-actin F: GAAGTGTGACGTTGACATCCG 60
R: ACTTGCGGTGCACGATGGAGG
aAnnealing temperature.
bForward primer.
cReverse primer.
doi:10.1371/journal.pone.0030344.t001
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The results are presented as the mean 6 SEM. Data were
analyzed by one-way ANOVA and LSD tests using the SPSS 13.0
software (SPSS Inc., Chicago, IL, USA). The difference was
considered statistically significant at P,0.05.
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